Breaking News Instant updates and real-time market news.

TEVA

Teva

$42.12

0.33 (0.79%)

09:12
10/18/16
10/18
09:12
10/18/16
09:12

Teva reports receipt of FDA warning letter related to plant inspection

In a regulatory filing, Teva Pharmaceutical disclosed that the company received a Warning Letter from the U.S. Food and Drug Administration connected with an FDA current Good Manufacturing Practices inspection of the company's Godollo manufacturing facility, which was conducted January 21, 2016 through January 29, 2016. The letter cites deficiencies in manufacturing operations and laboratory controls, and in the company's data integrity program. "Teva has undertaken corrective actions to address both the specific concerns raised by investigators as well as the underlying causes of those concerns. Communication with the FDA is ongoing. Teva will respond to the Warning Letter on November 4, 2016," the company stated.

  • 06

    Nov

  • 15

    Nov

TEVA Teva
$42.12

0.33 (0.79%)

10/06/16
WELS
10/06/16
NO CHANGE
WELS
Wells calls Teva partnership with Celltrion 'good news'
Wells Fargo analyst David Maris views Teva Pharmaceutical's partnership to commercialize two of Celltrion's monoclonal antibody biosimilar candidates as "good news." Teva is now a "little more firmly in the biosimilar game," Maris tells investors in a research note. He likes that the initial cash outflow is small and the partner. Maris has an Outperform rating on Teva.
10/07/16
LEER
10/07/16
NO CHANGE
Target $57
LEER
Outperform
Teva price target lowered to $57 from $61 at Leerink
Leerink analyst Jason Gerberry lowered his price target for Teva to $57 from $61 and trimmed his estimates to reflect near-term headwinds and a more conservative Copaxone outlook. The analyst continues to view a generic Copaxone launch in late the second half of 2017 as a risk. Nonetheless, Gerberry reiterates an Outperform rating on the stock as he views shares as attractively valued despite near-term EPS concerns and believes investor attention will eventually pivot to Teva's attractive late stage pipeline.
10/11/16
LEHM
10/11/16
UPGRADE
Target $19
LEHM
Overweight
Momenta upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Douglas Tsao upgraded Momenta Pharmaceuticals to Overweight after attending the consolidated Copaxone 40mg trial. The analyst sees low risk of Momenta being blocked from the 40mg opportunity past 2018 and views the stock's risk/reward as "compelling" at current levels. Tsao believes there is a "good likelihood" that Sandoz, Momenta's partner, launches Copaxone 40mg at-risk as soon as February 2017 upon FDA approval when the 30-month stay expires. The analyst raised his price target for Momenta shares to $19 from $13.
10/12/16
LEER
10/12/16
NO CHANGE
Target $70
LEER
Outperform
Neurocrine recent selloff a buying opportunity, says Leerink
Leerink analyst Paul Matteis views the 18% pullback in shares of Neurocrine Biosciences (NBIX) over the past few weeks as a buying opportunity. The analyst finds the catalyst for the selloff "difficult to pinpoint," but notes he's been receiving questions from investors on the size of the market opportunity for vesicular monoamine transporters in Tardive Dyskinesia. A doctor survey suggests a target market of 300,000 TD patients for Neurocrine's and Teva's VMAT2 inhibitors, which is enough to offer a "significant revenue opportunity" for both drugs, Matteis tells investors in a research note. Further, the analyst believes the upcoming Phase II data in Tourette's Syndrome, which he sees as having a high probability of success, offers a "nice catalyst for investors" into Q1 of next year. Matteis reiterates an Outperform rating on Neurocrine with a $70 price target.

TODAY'S FREE FLY STORIES

02:50
12/07/16
12/07
02:50
12/07/16
02:50
General news
FX Update: The dollar has traded steady-to-firmer »

FX Update: The dollar…

VRA

Vera Bradley

$14.67

-0.07 (-0.47%)

20:25
12/06/16
12/06
20:25
12/06/16
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

WPPGY

WPP PLC

$105.77

-1.18 (-1.10%)

, FB

Facebook

$117.31

-0.12 (-0.10%)

20:11
12/06/16
12/06
20:11
12/06/16
20:11
Periodicals
WPP CEO says spending about $70M with Snapchat, WSJ says »

Speaking earlier Tuesday…

WPPGY

WPP PLC

$105.77

-1.18 (-1.10%)

FB

Facebook

$117.31

-0.12 (-0.10%)

GOOG

Alphabet

$759.11

-3.41 (-0.45%)

GOOGL

Alphabet Class A

$776.18

-2.04 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 15

    Jan

GLT

Glatfelter

$24.29

0.67 (2.84%)

20:09
12/06/16
12/06
20:09
12/06/16
20:09
Downgrade
Glatfelter rating change  »

Glatfelter downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RPRX

Repros Therapeutics

$1.91

-0.04 (-2.05%)

20:06
12/06/16
12/06
20:06
12/06/16
20:06
Hot Stocks
Repros participates in FDA meeting, says plans meeting to discuss Phase 3 design »

Repros Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$185.85

-0.95 (-0.51%)

, SSNLF

Samsung

19:57
12/06/16
12/06
19:57
12/06/16
19:57
Hot Stocks
Electric car startup partners with Samsung SDI on 'breakthrough' battery tech »

Electric vehicle startup…

TSLA

Tesla

$185.85

-0.95 (-0.51%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 08

    Dec

  • 14

    Dec

  • 10

    Jan

SBMRY

SABMiller

, BUD

AB InBev

$104.05

0.79 (0.77%)

19:34
12/06/16
12/06
19:34
12/06/16
19:34
Periodicals
Bain Capital exits auction for European SABMiller brands, Reuters says »

Private equity firm Bain…

SBMRY

SABMiller

BUD

AB InBev

$104.05

0.79 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$46.86

1.28 (2.81%)

19:27
12/06/16
12/06
19:27
12/06/16
19:27
Hot Stocks
Senators: AutoNation resumption of recalled vehicle sales 'deeply troubling' »

U.S. Senators Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$152.24

0.08 (0.05%)

19:21
12/06/16
12/06
19:21
12/06/16
19:21
Periodicals
Boeing contacts Trump team after Air Force One tweets, Bloomberg says »

Following President-elect…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$152.24

0.08 (0.05%)

18:58
12/06/16
12/06
18:58
12/06/16
18:58
Hot Stocks
White House press secretary: Air Force One claims appear misrepresentative »

Responding to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$52.37

0.17 (0.33%)

, RDS.B

Royal Dutch Shell

$55.72

0.21 (0.38%)

18:51
12/06/16
12/06
18:51
12/06/16
18:51
Periodicals
Japan-based Idemitsu plans purchase of Showa Shell stake, Nikkei says »

Japan's Idemitsu…

RDS.A

Royal Dutch Shell

$52.37

0.17 (0.33%)

RDS.B

Royal Dutch Shell

$55.72

0.21 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$117.88

0.32 (0.27%)

18:48
12/06/16
12/06
18:48
12/06/16
18:48
Periodicals
Toyota plans to improve overall fuel economy by 20%, Nikkei reports »

Toyota plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AYA

Amaya

$14.60

0.2 (1.39%)

18:35
12/06/16
12/06
18:35
12/06/16
18:35
Periodicals
Amaya holder SpringOwl: Baazov bid 'raises a lot of questions,' Bloomberg says »

Speaking in a Bloomberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$185.85

-0.95 (-0.51%)

18:30
12/06/16
12/06
18:30
12/06/16
18:30
Hot Stocks
Tesla to recall certain NEMA 14-30, 10-30, 6-50 charging adapters »

Tesla said that it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 10

    Jan

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:21
12/06/16
12/06
18:21
12/06/16
18:21
Hot Stocks
Allegiant Travel says estimated November TRASM change (2.7%)-(2.3%) »

November estimated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:14
12/06/16
12/06
18:14
12/06/16
18:14
Hot Stocks
Allegiant Travel sees Q1 system departures up 14%-18%, ASMs up 10%-14% »

Sees Q1 scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNP

Tsakos Energy

$4.82

0.16 (3.43%)

18:13
12/06/16
12/06
18:13
12/06/16
18:13
Hot Stocks
Tsakos Energy announces four new time charter contracts »

Tsakos Energy Navigation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:12
12/06/16
12/06
18:12
12/06/16
18:12
Hot Stocks
Allegiant Travel sees Q4 system departures up 17%-19%, ASMs up 12%-14% »

Sees Q4 scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:11
12/06/16
12/06
18:11
12/06/16
18:11
Hot Stocks
Breaking Hot Stocks news story on Allegiant Travel »

Allegiant Travel sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:09
12/06/16
12/06
18:09
12/06/16
18:09
Hot Stocks
Allegiant Travel revises Q4 TRASM view to (6%)-(4.5%) from (7.5%)-(5.5%) »

"November close in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:07
12/06/16
12/06
18:07
12/06/16
18:07
Hot Stocks
Allegiant Travel reports preliminary November traffic up 8.7% »

Reports November…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMAB

OMA Airports

$36.17

0.23 (0.64%)

18:01
12/06/16
12/06
18:01
12/06/16
18:01
Hot Stocks
OMA Airports reports November passenger traffic up 11.3% »

OMA Airports reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

III

Information Services

$3.90

0.04 (1.04%)

18:00
12/06/16
12/06
18:00
12/06/16
18:00
Hot Stocks
Chevrillon raises passive stake in Information Services to 13.55% from 7.2% »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

SAGE Therapeutics

$55.68

3.86 (7.45%)

17:59
12/06/16
12/06
17:59
12/06/16
17:59
Recommendations
SAGE Therapeutics analyst commentary  »

BMO ups SAGE target to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AKS

AK Steel

$10.55

-0.1 (-0.94%)

17:47
12/06/16
12/06
17:47
12/06/16
17:47
Hot Stocks
AK Steel to increase base prices for all stainless products »

AK Steel said that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.